Fo
Forma Therapeutics
Watertown MAFounded 2007200 employees
Private CapbiotechAcquiredHematology
Platform: SCD HbF
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| FOR-7299 | FOR-7299 | Phase 3 | 1 | PARP | SLEUrothelial Ca | ||
| FOR-4809 | FOR-4809 | Phase 1 | 2 | PLK4 | ASMCC | ||
| Motaderotide | FOR-7722 | Phase 2/3 | 2 | ALK | Pancreatic Ca | ||
| FOR-9610 | FOR-9610 | Phase 2 | 2 | TYK2 | NBSCLC |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (6)